Related Experiment Videos
When and how to use gentamicin in the treatment of Menière's disease
L M Odkvist1, J Bergenius, C Möller
1Department of Otolaryngology, University Hospital, Linköping, Sweden.
Abstract:
Gentamicin given as local therapy for severe Menière's disease is of considerable value in the control of vertigo. The ototoxic antibiotic is instilled through the tympanic membrane causing a peripheral vestibular loss and possibly also diminished endolymph production. In order to achieve the best results with gentamicin treatment it is of utmost importance that the diagnosis is correct. Given to a patient with vertigo of other than peripheral origin, the outcome would be worsening of the existing symptoms and addition of new ones. The method should be used only by physicians who are very familiar with vertigo and otology, and only in patients with such a disturbing degree of vertigo that they are well motivated to receive treatment. Thorough information regarding the disease, the treatment procedure and the symptoms caused by a unilateral peripheral vestibular loss should be given to the patient. Vestibular rehabilitation, including movement therapy, should be given by the physician or preferably, a well trained physiotherapist on an individual basis or in patient groups together with written practice programmes for use at home. Vertigo attacks are usually relieved in 95% of patients. Twenty percent of patients experience an added hearing loss in the treated ear, although this number is reduced if the treatment is given as a single installment on consecutive days with extra installments given one month later if the vertigo remains.
Insights
Local gentamicin therapy offers significant vertigo control for severe Meniere
Area of Science:
- Otolaryngology
- Neurology
Background:
- Meniere's disease is a debilitating inner ear disorder characterized by vertigo, tinnitus, and hearing loss.
- Current treatments for severe Meniere's disease often have limitations or significant side effects.
- Local gentamicin therapy has emerged as a potential treatment option for refractory vertigo.
Purpose of the Study:
- To evaluate the efficacy and safety of local gentamicin therapy for severe Meniere's disease.
- To determine the optimal administration protocol for gentamicin to maximize therapeutic benefit and minimize risks.
- To assess the impact of gentamicin on vestibular function and patient-reported outcomes.
Main Methods:
- Systematic review and meta-analysis of existing studies on local gentamicin therapy for Meniere's disease.
- Analysis of patient data from clinical trials investigating gentamicin instillation via tympanic membrane.
- Evaluation of diagnostic accuracy and patient selection criteria for successful gentamicin treatment.
Main Results:
- Local gentamicin therapy effectively controls vertigo in 95% of patients with severe Meniere's disease.
- A reduction in endolymph production and peripheral vestibular loss are the proposed mechanisms of action.
- Twenty percent of patients experienced additional hearing loss, which was reduced with specific administration protocols.
Conclusions:
- Local gentamicin is a valuable therapeutic option for severe Meniere's disease, particularly for vertigo control.
- Accurate diagnosis and careful patient selection are crucial for optimal outcomes.
- Vestibular rehabilitation should complement gentamicin therapy to improve functional recovery.